Acute tumor lysis syndrome associated with concurrent biochemotherapy of metastatic melanoma: A case report and review of the literature

Cancer

Volumn 85, Issue 5, 1999, Pages 1055-1059

  Castro, Michael P ^a   VanAuken, Jean ^a   Spencer Cisek, Patricia ^b   Legha, Sewa ^c   Sponzo, Robert W ^a  

^a Glens Falls Cancer Center ^*  (United States)

^b Glens Falls Hospital   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Biochemotherapy; Immunotherapy; Melanoma; Oncologic emergency; Treatment complications; Tumor lysis syndrome

Indexed keywords

ALPHA INTERFERON; CISPLATIN; INTERLEUKIN 2;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CASE REPORT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOPROLIFERATIVE DISEASE; MALE; MELANOMA; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACUTE DISEASE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARTATE AMINOTRANSFERASES; CALCIUM; CISPLATIN; CREATININE; DACARBAZINE; FATAL OUTCOME; HUMANS; INTERFERON-ALPHA; INTERLEUKIN-2; L-LACTATE DEHYDROGENASE; MALE; MELANOMA; MIDDLE AGED; PHOSPHORUS; SKIN NEOPLASMS; TUMOR LYSIS SYNDROME; URIC ACID; VINBLASTINE;

EID: 0032967337     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990301)85:5<1055::AID-CNCR7>3.0.CO;2-3     Document Type: Article

References (40)

1. Warrell RP. Metabolic emergencies. In: DeVita VT, Hellman S, Rosenberg SA. Cancer: principles and practice of oncology. 4th edition. Philadelphia: J. B. Lippincott, 1993: 2135.
2. Morris JC, Holland JE. Oncologic emergencies. In: Holland JF, Frei E, Bast RC, Kufe DW, Morton DL, Weichselbaum RR. Cancer medicine. 3rd edition. Philadelphia: Lea & Febiger, 1993:2460-1.
3. Arrambide K, Toto RD. Tumor lysis syndrome. Semin Nephrol 1993;13:273-80.
4. Jasek AM, Day HJ. Acute spontaneous tumor lysis syndrome. Am J Hematol 1994;47:129-31.
5. Malik IA, Abubakar S, Alam F, Khan A. Dexamethasone-induced tumor lysis syndrome in high-grade non-Hodgkin's lymphoma. South Med J 1994;87(3 Suppl):409-11.
6. Hande KR, Garrow GC. Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma. Am J Med 1993;94(2 Suppl):133-9.
7. Sparano J, Ramirez M, Wiernik PH. Increasing recognition of corticosteroid-induced tumor lysis syndrome in non-Hodgkin's lymphoma. Cancer 1990;65(5 Suppl):1072-3.
8. Cohen LF, Balow JE, Magrath IT, Poplack DG, Ziegler JL. Acute tumor lysis syndrome: a review of 37 patients with Burkitt's lymphoma. Am J Med 1980;68(4 Suppl):486-91.
9. Boccia RV, Longo DL, Lieber ML, Jaffe ES, Fisher RI. Multiple recurrences of acute tumor lysis syndrome in an indolent non-Hodgkin's lymphoma. Cancer 1985;56(9 Suppl): 2295-7.
10. Dhingra K, Newcom SR. Acute tumor lysis syndrome in non-Hodgkin lymphoma induced by dexamethasone. Am J Hematol 1988;29(2 Suppl):115-6.
11. Fleming DR, Doukas MA. Acute tumor lysis syndrome in hematologic malignancies. Leuk Lymphoma 1992;8(4-5 Suppl):315-8.
12. List AF, Kummet TD, Adams JD, Chun HG. Tumor lysis syndrome complicating treatment of chronic lymphocytic leukemia with fludarabine phosphate. Am J Med 1990;89(3 Suppl):388-9.
13. Przepiorka D, Gonzales-Chambers R. Acute tumor lysis syndrome in a patient with chronic myelogenous leukemia in blast crisis: role of high-dose Ara-C. Bone Marrow Transplant 1990;6(4 Suppl):281-2.
14. McCroskey RD, Mosher DF, Spencer CD, Prendergast E, Longo WL. Acute tumor lysis syndrome and treatment response in patients treated for refractory chronic lymphocytic leukemia with short-course, high-dose cytosine arabinoside, cisplatin, and etoposide. Cancer 1990;66(2 Suppl): 246-50.
15. Gomez GA, Han T. Acute tumor lysis syndrome in prolymphocytic leukemia. Arch Intern Med 1987;147(2 Suppl):375-6.
16. Smith RE, Stoiber TR. Acute tumor lysis syndrome in prolymphocytic leukemia. Am J Med 1990;88(5 Suppl): 547-8.
17. Sklarin NT, Markham M. Spontaneous recurrent tumor lysis syndrome in breast cancer. Am J Clin Oncol 1995;18(1 Suppl):71-3.
18. Drakos P, Bar-Ziv J, Catane R. Tumor lysis syndrome in nonhematologic malignancies: report of a case and review of the literature. Am J Clin Oncol 1994;17(6 Suppl):502-5.
19. Barton JC. Tumor lysis syndrome in nonhematopoietic neoplasms. Cancer 1989;64(3 Suppl):738-40.
20. Stark ME, Dyer MC, Coonley CJ. Fatal acute tumor lysis syndrome with metastatic breast carcinoma. Cancer 1987; 60(4 Suppl):762-4.
21. Cech P, Block JB, Cone LA, Stone R. Tumor lysis syndrome after tamoxifen flare [letter]. N Engl J Med 1986;315(4 Suppl): 263-4.
22. Hussein AM, Feun LG. Tumor lysis syndrome after induction chemotherapy in small-cell lung carcinoma. Am J Clin Oncol 1990;13(1 Suppl):10-3.
23. Vogelzang NJ, Nelimark RA, Nath KA. Tumor lysis syndrome after induction chemotherapy of small-cell bronchogenic carcinoma. JAMA 1983;249(4 Suppl):513-4.
24. Kalemkerian GP, Darwish B, Varterasian ML. Tumor lysis syndrome in small cell carcinoma and other solid tumors. Am J Med 1997;103(5 Suppl):363-7.
25. Kattan J, Culine S, Tavakoli-Razavi T, Kramar A, Droz JP. Acute tumor lysis syndrome in poor-risk germ cell tumors: does it exist? Support Care Cancer 1994;2(2 Suppl):128-31.
26. Yokoi K, Miyazawa N, Kano Y, Akutsu M, Mori K, Tominaga K, et al. Tumor lysis syndrome in invasive thymoma with peripheral blood T-cell lymphocytosis. Am J Clin Oncol 1997;20(1 Suppl):86-9.
27. Gold JE, Malamud SC, LaRosa F, Osband ME. Adoptive chemoimmunotherapy using ex vivo activated memory T-cells and cyclophosphamide: tumor lysis syndrome of a metastatic soft tissue sarcoma. Am J Hematol 1993;44(1 Suppl):42-7.
28. Khan J, Broadbent VA. Tumor lysis syndrome complicating treatment of widespread metastatic abdominal rhabdomyosarcoma. Pediatr Hematol Oncol 1993:10(2 Suppl):151-5.
29. Bilgrami SF, Fallon BG. Tumor lysis syndrome after combination chemotherapy for ovarian cancer. Med Pediatr Oncol 1993;21(7 Suppl):521-4.
30. Dirix LY, Prove A, Becquart D, Wouters E, Vermeulen P, Van Oosterom A. Tumor lysis syndrome in a patient with metastatic Merkel cell carcinoma. Cancer 1991;67(8 Suppl):2207-10.
31. Tomlinson GC, Solberg LA Jr. Acute tumor lysis syndrome with metastatic medulloblastoma: a case report. Cancer 1984;53(8 Suppl):1783-5.
32. Shamseddine AI, Khalil AM, Wehbeh MH. Acute tumor lysis syndrome with squamous cell carcinoma of the vulva. Gynecol Oncol 1993;51(2 Suppl):258-60.
33. Fleming DR, Henslee-Downey PJ, Coffey CW. Radiation-induced acute tumor lysis syndrome in the bone marrow transplant setting. Bone Marrow Transplant 1991;8(3 Suppl):235-6.
34. Simmons ED, Somberg KA. Acute tumor lysis syndrome after intrathecal methotrexate administration. Cancer 1991; 67(8 Suppl):2062-5.
35. Lobe TE, Karkera MS, Custer MD, Shenefelt RE, Douglass EC. Fatal refractory hyperkalemia due to tumor lysis during primary resection for hepatoblastoma. J Pediatr Surg 1990; 25(2 Suppl):249-50.
36. Legha SS, Ring S, Bedikian A, Eton O, Buzaid AC, Plager C, et al. Treatment of metastatic melanoma with combined chemotherapy containing cisplatin, vinblastine and dacarbazine (CVD) and biotherapy using interleukin-2 and interferon-alpha. Ann Oncol 1996;7(8 Suppl):827-35.
37. Legha SS. Durable complete responses in metastatic melanoma treated with interleukin-2 in combination with interferon-alpha and chemotherapy. Semin Oncol 1997;24(1 Suppl 4):S39-43.
38. Legha SS, Ring S, Eton O, Bedikian A, Plager C, Papadopoulos N. Development and results of biochemotherapy in metastatic melanoma: the University of Texas M. D. Anderson Cancer Center experience. Cancer J Sci Am 1997;3(1 Suppl);S9-15.
39. Antoine EC, Benhammouda A, Bernard A, Youssef A, Mortier N, Gozy M, et al. Salpetriere Hospital experience with biochemotherapy in metastatic melanoma. Cancer J Sci Am 1997;3(1 Suppl):S16-21.
40. Legha SS, Ring S, Eton O, Bedikian A, Buzaid C, Plager C, et al. Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazin, interferon alpha, and interleukin-2 for patients with metastatic melanoma. J Clin Oncol 1998;16(5 Suppl):1752-9.